Literature DB >> 12890306

Long-term symptomatic status of bipolar I vs. bipolar II disorders.

Lewis L Judd1, Pamela J Schettler, Hagop S Akiskal, Jack Maser, William Coryell, David Solomon, Jean Endicott, Martin Keller.   

Abstract

Weekly affective symptom severity and polarity were compared in 135 bipolar I (BP I) and 71 bipolar II (BP II) patients during up to 20 yr of prospective symptomatic follow-up. The course of BP I and BP II was chronic; patients were symptomatic approximately half of all follow-up weeks (BP I 46.6% and BP II 55.8% of weeks). Most bipolar disorder research has concentrated on episodes of MDD and mania and yet minor and subsyndromal symptoms are three times more common during the long-term course. Weeks with depressive symptoms predominated over manichypomanic symptoms in both disorders (31) in BP I and BP II at 371 in a largely depressive course (depressive symptoms=59.1% of weeks vs. hypomanic=1.9% of weeks). BP I patients had more weeks of cyclingmixed polarity, hypomanic and subsyndromal hypomanic symptoms. Weekly symptom severity and polarity fluctuated frequently within the same bipolar patient, in which the longitudinal symptomatic expression of BP I and BP II is dimensional in nature involving all levels of affective symptom severity of mania and depression. Although BP I is more severe, BP II with its intensely chronic depressive features is not simply the lesser of the bipolar disorders; it is also a serious illness, more so than previously thought (for instance, as described in DSM-IV and ICP-10). It is likely that this conventional view is the reason why BP II patients were prescribed pharmacological treatments significantly less often when acutely symptomatic and during intervals between episodes. Taken together with previous research by us on the long-term structure of unipolar depression, we submit that the thrust of our work during the past decade supports classic notions of a broader affective disorder spectrum, bringing bipolarity and recurrent unipolarity closer together. However the genetic variation underlying such a putative spectrum remains to be clarified.

Entities:  

Mesh:

Year:  2003        PMID: 12890306     DOI: 10.1017/S1461145703003341

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  79 in total

1.  Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature.

Authors:  Chris B Aiken; Carolyn Orr
Journal:  Psychiatry (Edgmont)       Date:  2010-05

2.  Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder.

Authors:  Lewis L Judd; Hagop S Akiskal
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

3.  Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop Akiskal; William Coryell; Jan Fawcett; Jess G Fiedorowicz; David A Solomon; Martin B Keller
Journal:  J Affect Disord       Date:  2012-02-06       Impact factor: 4.839

4.  Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.

Authors:  Kamyar Keramatian; Trisha Chakrabarty; Lakshmi N Yatham
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

5.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

6.  Clinical correlates of suicidality and self-injurious behaviour among Canadian adolescents with bipolar disorder.

Authors:  Diana Khoubaeva; Mikaela Dimick; Vanessa H Timmins; Lisa M Fiksenbaum; Rachel H B Mitchell; Ayal Schaffer; Mark Sinyor; Benjamin I Goldstein
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-05-24       Impact factor: 4.785

7.  Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry.

Authors:  Carol A Janney; Andrea Fagiolini; Holly A Swartz; John M Jakicic; Robert G Holleman; Caroline R Richardson
Journal:  J Affect Disord       Date:  2013-09-18       Impact factor: 4.839

8.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005

Review 9.  Problems in the boundaries of bipolar disorders.

Authors:  Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

10.  Cholesterol and affective morbidity.

Authors:  Jess G Fiedorowicz; Narasimha M Palagummi; Ole Behrendtsen; William H Coryell
Journal:  Psychiatry Res       Date:  2009-12-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.